Ulrich Dauer, Chief Executive Officer at Vivoryon Therapeutics AG, holds 38.56K shares in Vivoryon Therapeutics AG (Ticker: GB:0R3M). Most recently, Ulrich Dauer Bought €4,761 shares of Vivoryon Therapeutics AG on Apr 04, 2022 for an estimated value of 49.99K.